Biohaven Ltd. (BHVN) FinancialsBHVNFinancialBiohaven Ltd.

Evaluating the bottom line, Biohaven Ltd. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -799.46%, provide a clear picture of how effectively BHVN converts its operational activities into shareholder value.

In the context of the broader market, BHVN competes directly with industry leaders such as HRMY and OCUL. With a market capitalization of $2.56B, it holds a leading position in the sector. When comparing efficiency, BHVN's gross margin of N/A stands against HRMY's 75.81% and OCUL's 85.08%. Such benchmarking helps identify whether Biohaven Ltd. is trading at a premium or discount relative to its financial performance.

Biohaven has reported negative net income for several quarters, with Q2 2026 showing a loss of -137 million. The current ratio is strong at 4.73, indicating good short-term liquidity, but the debt to equity ratio has surged to 2123.06%, signaling potential financial instability.